Puig Brands, S.A. Class B
19.29
EUR
-0.30
(-1.53%)
ISIN
ES0105777017
Return %
Stock
S&P 500
1Y
35.85
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Jose Manuel Albesa Muniesa
- Full Time Employees
- 13,016
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- Puig Tower 2 Barcelona CT Spain 08902
- IPO Date
- May 3, 2024
- Website
- puig.com
- Similar Companies
- Business
- Puig Brands SA engages in the creation, development, marketing, manufacturing, and sale of fragrances, fashion, makeup, and skincare products worldwide. Founded in 1914 by Antonio Puig Castelló and headquartered in Barcelona, Spain, the company operates through segments including Fragrance and Fashion, Makeup, and Skincare; it markets its portfolio in over 150 countries with direct presence in 32 markets and employs more than 11,000 people. Core offerings encompass prestige fragrances and fashion from owned brands such as Rabanne, Carolina Herrera, Jean Paul Gaultier, Nina Ricci, Dries Van Noten, Byredo, Penhaligon's, and L'Artisan Parfumeur; skincare brands including Uriage, Apivita, Dr. Barbara Sturm, Kama Ayurveda, and Loto del Sur; makeup from Charlotte Tilbury; and licensed beauty products for Christian Louboutin, Antonio Banderas, Adolfo Dominguez, and others, with skincare lines featuring cleansers, toners, moisturizers, serums, body care, exfoliators, acne treatments, facial masks, and sun care; makeup products include foundations, concealers, lipsticks, lip glosses, eyeliners, blushes, mascaras, and eyeshadows. Recent developments include the 2024 initial public offering on the Spanish Stock Exchange, valuing the company at nearly €14 billion and resulting in inclusion in the IBEX 35 index with a corporate rebranding; acquisitions of majority stakes in Charlotte Tilbury (initially in 2020, with full ownership agreement by 2031), Byredo and Kama Ayurveda/Loto del Sur in 2022, and Dr. Barbara Sturm in 2024; expansion of U.S. operations with a Miami regional hub and New York offices at Rockefeller Center in 2024; inauguration of a second headquarters tower (Torre Puig T2) in Barcelona in 2024; and strong financial growth to €4.8 billion in net revenue and €551 million in adjusted net profit in 2024. As a subsidiary of family-controlled Puig SL, the company targets prestige and luxury segments serving consumers in Europe, the Middle East, Africa, the Americas, and Asia-Pacific through owned brands, licenses, subsidiaries, and production facilities in Europe and India.